Bausch Health
BHC
#3644
Rank
HK$22.85 B
Marketcap
HK$62.04
Share price
-2.57%
Change (1 day)
14.80%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : HK$167.41 Billion

According to Bausch Health 's latest financial reports the company's total debt is HK$167.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31HK$174.85 B7.77%
2022-12-31HK$162.24 B-8.15%
2021-12-31HK$176.64 B-4.76%
2020-12-31HK$185.47 B-8.03%
2019-12-31HK$201.67 B5.96%
2018-12-31HK$190.33 B-4.26%
2017-12-31HK$198.79 B-14.11%
2016-12-31HK$231.44 B-4%
2015-12-31HK$241.07 B104.01%
2014-12-31HK$118.17 B-12.32%
2013-12-31HK$134.76 B57.69%
2012-12-31HK$85.46 B65.45%
2011-12-31HK$51.65 B79.82%
2010-12-31HK$28.72 B844.45%
2009-12-31HK$3.04 B517.92%
2008-12-31HK$0.49 B
2006-12-31HK$3.19 B-5.73%
2005-12-31HK$3.38 B-9%
2004-12-31HK$3.72 B-40.9%
2003-12-31HK$6.29 B8.06%
2002-12-31HK$5.82 B1519.19%
2001-12-31HK$0.35 B-93.75%
2000-12-31HK$5.76 B439.35%
1999-12-31HK$1.06 B8.65%
1998-12-31HK$0.98 B2489.16%
1997-12-31HK$37.97 M-29.87%
1996-12-31HK$54.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.09 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA